Distant organ metastasis patterns and prognosis of cervical adenocarcinoma: a population-based retrospective study
View abstract on PubMed
Summary
This summary is machine-generated.Distant organ metastasis in cervical adenocarcinoma most commonly affects single organs like the lungs. Treatments including surgery, radiotherapy, and chemotherapy may improve survival for these patients.
Area Of Science
- Oncology
- Gynecologic Oncology
- Cancer Metastasis Research
Background
- Cervical adenocarcinoma is a frequent histological subtype of cervical cancer.
- Prognosis for cervical adenocarcinoma with distant organ metastases is not well-defined.
- Understanding metastasis patterns is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the patterns of distant organ metastasis in cervical adenocarcinoma.
- To analyze the prognostic impact of distant organ metastasis in cervical adenocarcinoma.
- To evaluate the survival benefits of different treatment modalities for metastatic cervical adenocarcinoma.
Main Methods
- Utilized data from the Surveillance, Epidemiology, and End Results (SEER) database (2010-2019).
- Employed Cox regression, Kaplan-Meier, and log-rank analyses for statistical evaluation.
- Identified patterns and prognostic factors of distant organ metastasis.
Main Results
- Cervical adenocarcinoma predominantly metastasizes to single organs (73.3%), with lungs being the most common site, followed by liver and bone.
- Bone metastasis showed a median survival of 12 months, slightly longer than other metastatic sites.
- Distant metastasis, advanced age, positive lymph nodes, higher AJCC stages, larger tumor size, and higher tumor grade were associated with poor prognosis (p < 0.001).
- Surgical intervention, radiotherapy, and chemotherapy demonstrated potential benefits for patients with distant metastases.
Conclusions
- Distant organ metastasis is an independent negative prognostic factor for cervical adenocarcinoma.
- Treatment modalities including surgery, radiotherapy, and chemotherapy can offer survival advantages to patients with distant organ metastases.

